Brief: Kronos Bio Reports Recent Business Progress And Second Quarter Financial Results
Aug 12 (Reuters) - Kronos Bio Inc KRON.O :
* KRONOS BIO REPORTS RECENT BUSINESS PROGRESS AND SECOND
QUARTER
FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.53 INCLUDING ITEMS
* Q2 EARNINGS PER SHARE ESTIMATE $-0.62 -- REFINITIV IBES
DATA
* $419.3 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS
AS OF
JUNE 30, 2021
Source text for Eikon: ID:nGNX2nqgDn
Further company coverage: KRON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kronos Bio
See all newsBrief: Kronos Bio Inc - Terminates Office Lease At 301 Binney Street - SEC Filing
Brief: Kronos Bio Inc - Enters Transition Agreement With Genentech
U.S. STOCKS ON THE MOVE - Ambarella, Dell, Nordstrom
U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
U.S. STOCKS ON THE MOVE-HP, Urban Outfitters, 3D Systems